VivoSeq
Other

Greater Trochanteric Pain Syndrome

1

Pipeline Programs↗

3

Active Trials↗

1

Companies Involved↗

Greater Trochanteric Pain Syndrome is an early-stage landscape with 1 program across 1 company. The most active players are Brixton Biosciences, Inc..

Intelligence

Pipeline Metrics

Competitive Density

19/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

B

Brixton Biosciences, Inc.

1 program

Preclinical

Pipeline

Programs by Phase

Preclinical1

Triamcinolone Acetate

Brixton Biosciences, Inc.

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

7

clinical trials

Completed2 · 29%
Unknown status1 · 14%
Withdrawn1 · 14%
Recruiting1 · 14%
Not yet recruiting1 · 14%
Active, not recruiting1 · 14%

Clinical Trials

Trial Activity

7 trials

Comparison Between Transarterial Musculoskeletal Embolization and Platelet-Rich Plasma Injection for the Treatment of Greater Trochanteric Pain Syndrome
Recruiting·UUnidade Local de Saúde do Alto Ave, EPE·Phase 2·NCT07396246·30 enrolled
Effectiveness of Ultrasound-Guided Percutaneous Neuromodulation (UG-PNM) on the Superior Gluteal Nerve in Patients With Greater Trochanteric Pain Syndrome (GTPS): A Pilot Study
Active, not recruiting·UUniversidad de Zaragoza·Preclinical·NCT06529783·50 enrolled
ReneuRx™ (Nerve Selective Therapy) Utilized in Lateral Hip Pain: A Multi-Center, Randomized, Controlled Trial (RENEU)
Not yet recruiting·BBrixton Biosciences, Inc.·Preclinical·NCT07568015·100 enrolled
Comparison of Ozone and Steroid Injection in Patients With Greater Trochanteric Pain Syndrome
Completed·SSultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey·N/A·NCT04420572·63 enrolled
Greater Trochanteric Pain Syndrome: Efficacy of Ultrasound Guided Platelet-rich Plasma vs Needle Tenotomy.
Completed·—·Phase 3·NCT04231357·81 enrolled
Steroid Injection for the Treatment of Greater Trochanteric Pain Syndrome
Withdrawn·EEmory University·Phase 4·NCT00863889
Efficacy of Platelet Rich Plasma vs. Corticosteroid Injections for Treating Greater Trochanteric Pain Syndrome
Unknown status·—·Phase 1·NCT02031367·50 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)